Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells.

S. A. Rosenberg

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)217-257
Number of pages41
JournalImportant advances in oncology
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Medicine(all)

Cite this